Wayland Group (MRRCF)

[Santiagero]

finally:

https://web.tmxmoney.com/article.php?newsid=5397732162605939…

TORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that its joint venture DEMECAN GmbH (“DEMECAN”), of which it holds 50% with an option to increase to 60% has been awarded three lots of domestic cannabis production in Germany by the Federal Institute for Drugs and Medical Devices (“BfArM”), after the withdrawal of a competitor’s complaint following an oral court hearing.

DEMECAN is awarded three lots of thirteen total, which makes DEMECAN one of three companies globally to achieve a cannabis license for domestic production in Germany, out of 79 applicants.

DEMECAN will now begin production within Wayland’s Ebersbach facility, following completion of upgrades to quality and security systems.

Additionally, Wayland GmbH has received its narcotics license from the Bundesopiumstelle, the narcotics division of BfArM.